Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

58%

7 trials in Phase 3/4

Results Transparency

40%

4 of 10 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 3

4(33.3%)

N/A

4(33.3%)

Phase 4

3(25.0%)

Phase 2

1(8.3%)

12Total

Phase 3(4)

N/A(4)

Phase 4(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT00797459Not ApplicableCompleted

Safety & Tolerability Study That Compares Restylane to Restylane With Lidocaine While Correcting Wrinkles in the Nasolabial Folds

Role: lead

NCT01396811Phase 3Completed

Topical Antifungal Treatment for Tinea Pedis

Role: lead

NCT01396785Phase 3Completed

Topical Antifungal Treatment for Tinea Pedis

Role: lead

NCT01342315Phase 3Completed

Topical Antifungal Treatment for Tinea Cruris

Role: lead

NCT01565915Not ApplicableUnknown

Efficacy and Safety of Perlane-L in the Correction of Midface Volume Deficit

Role: lead

NCT01621399Phase 3Completed

Safety and Efficacy Study to Treat Bacterial Vaginosis

Role: lead

NCT00977704Phase 4Completed

Study of Restylane and Perlane in the Correction of Peri-Oral Wrinkles

Role: lead

NCT01703793Phase 2Completed

Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

Role: lead

NCT01413763Phase 4Unknown

Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis

Role: lead

NCT00935272Not ApplicableCompleted

Safety/Efficacy Study of Restylane® in Lip Augmentation

Role: lead

NCT01206348Phase 4Completed

Combination Treatment for Moderate to Severe Acne

Role: lead

NCT00823069Not ApplicableCompleted

Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose

Role: lead

All 12 trials loaded